Mariko Takahashi

Mariko Takahashi

Auto-generated profile, based on publicly available information

Mariko Takahashi

Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2024 in Cell
Verified
Journal Article
Closed access
MTMariko Takahashi
Mariko Takahashi
HCHarrison B. Chong
Harrison B. Chong
SZSiwen Zhang
Siwen Zhang
TYTzu-Yi Yang
Tzu-Yi Yang
MLMatthew J. Lazarov
Matthew J. Lazarov
LBLiron Bar-Peled
Liron Bar-Peled

25 March 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
MTMariko Takahashi
Mariko Takahashi
CLChan-Wang J. Lio
Chan-Wang J. Lio
ACAnaamika Campeau
Anaamika Campeau
MSMartin Steger
Martin Steger
FAFerhat Ay
Ferhat Ay
SSSonia Sharma
Sonia Sharma

24 July 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
RDRekha Dhanwani
Rekha Dhanwani
MTMariko Takahashi
Mariko Takahashi
IMIan T. Mathews
Ian T. Mathews
CLCamille Lenzi
Camille Lenzi
ARArtem Romanov
Artem Romanov
SSSonia Sharma
Sonia Sharma
Metabolic analysis of ADA2-deficient cells shows that extracellular purine nucleosides trigger cellular innate immunity.

7 May 2026 in Science
Verified
Journal Article
Closed access
XZXingwu Zhou
Xingwu Zhou
XLXiang Ling
Xiang Ling
XSXiaoqi Sun
Xiaoqi Sun
ZWZiye Wan
Ziye Wan
TDTobias Dwyer
Tobias Dwyer
JMJames Moon
James Moon
Natural systems use metal ions to form ordered structures that regulate biological processes, inspiring the rational design of nanotherapeutics. The cyclic guanosine monophosphate–adenosine monophosphate synthase–stimulator of interferon genes (cGAS-STING) pathway drives antitumor immunity but has been difficult to activate systemically owing to poor pharmacology and toxicity. Here, we report CRYSTAL, a structurally ordered intermetallic nanoparticle for potent systemic STING activation. CRYSTAL self-assembles from manganese ions intercalated with cyclic dinucleotides, enabling precise structural control. At an ultralow intravenous dose (0.003 milligrams per kilogram), CRYSTAL activated STING in mice, dogs, and nonhuman primates without cytokine release syndrome. CRYSTAL induced robust tumor regression in advanced murine and rabbit models, remodeled immunosuppressive environments, and promoted host STING–dependent CD8 + T cell priming. CRYSTAL activated interferon responses in human head and neck squamous cell carcinoma biopsies, underscoring its translational potential for cancer immunotherapy.

15 January 2019 in Science Signaling
Verified
Journal Article
Closed access
PDF file
MTMariko Takahashi
Mariko Takahashi
KIKumi Izawa
Kumi Izawa
MUMakoto Urai
Makoto Urai
YYYoshinori Yamanishi
Yoshinori Yamanishi
AMAkie Maehara
Akie Maehara
JKJiro Kitaura
Jiro Kitaura
Zymosan is a glucan that is a component of the yeast cell wall. Here, we determined the mechanisms underlying the zymosan-induced accumulation of neutrophils in mice. Loss of the receptor CD300b reduced the number of neutrophils recruited to dorsal air pouches in response to zymosan, but not in response to lipopolysaccharide (LPS), a bacterial membrane component recognized by Toll-like receptor 4 (TLR4). An inhibitor of nitric oxide (NO) synthesis reduced the number of neutrophils in the zymosan-treated air pouches of wild-type mice to an amount comparable to that in CD300b−/− mice. Treatment with clodronate liposomes decreased the number of NO-producing, CD300b+ inflammatory dendritic cells (DCs) in wild-type mice, thus decreasing NO production and neutrophil recruitment. Similarly, CD300b deficiency decreased the NO-dependent recruitment of neutrophils to zymosan-treated joint cavities, thus ameliorating subsequent arthritis. We identified phytosphingosine, a lipid component of zymosan, as a potential ligand of CD300b. Phytosphingosine stimulated NO production in inflammatory DCs and promoted neutrophil recruitment in a CD300b-dependent manner. Together, these results suggest that the phytosphingosine-CD300b interaction promotes zymosan-dependent neutrophil accumulation by inducing NO production by inflammatory DCs and that CD300b may contribute to antifungal immunity.

3 November 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
YCYoung Seok Cho
Young Seok Cho
XZXingwu Zhou
Xingwu Zhou
XSXiaoqi Sun
Xiaoqi Sun
ZWZiye Wan
Ziye Wan
JCJulia Crowther
Julia Crowther
JMJames Moon
James Moon
Toll-like receptor (TLR) agonists, as potent immunostimulatory adjuvants, play a critical role in linking the innate and adaptive immune responses. However, their antitumor effects as cancer immunotherapeutic agents have been limited. Here, we report our finding that manganese ion (Mn 2+ ) potentiates various TLR agonists, leading to robust activation of the TLR pathway and the stimulator of interferon genes (STING) pathway among innate immune cells. In particular, we have observed robust antitumor efficacy after intratumoral administration of a TLR3 agonist and Mn 2+ . To achieve systemic codelivery of TLR3 agonist and Mn 2+ , we have developed a low-molecular-weight poly(inosinic:cytidylic acid)-Mn 2+ coordination lipid nanoparticle (PLCMP). When administered intravenously in tumor-bearing mice, PLCMP successfully accumulated in tumor, induced innate immune activation, generated tumor-specific T cells, and exerted antitumor efficacy in TLR3- and STING-dependent manner without triggering overt toxicity. Moreover, PLCMP in combination with α-PD-1 therapy achieved long-lasting antitumor efficacy in multiple murine tumor models. Furthermore, vaccination with PLCMP carrying TC-1 tumor antigen peptide elicited strong antigen-specific CD8 + T cell responses and remodeled the tumor microenvironment, resulting in robust therapeutic efficacy. Overall, these results show that simultaneous activation of the TLR3 and STING pathways via PLCMP provides a promising strategy for immunotherapy and vaccination against cancer.